Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Methylene Blue in Septic Shock Patients Receiving Low-Dose Vasopressors
TCTR20250827006Phase 3Recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylene blue in septic shock, sponsored by Phramongkutklao Hospital. Started Sep 2025; status: recruiting.
02
Drugs
methylene blue
03
Conditions
septic shock
Beyond the preview
Go deeper on TCTR20250827006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250827006.